Werewolf Therapeutics adopts amended bylaws, elects directors at annual meeting

Werewolf Therapeutics, Inc.

Board adopted Third Amended and Restated Bylaws effective June 12, 2025, updating stockholder nomination and proposal procedures.
Stockholders elected Briggs Morrison, Michael Sherman, and Anil Singhal as Class I directors for three-year terms ending 2028.
Director vote results: Morrison 19.16M for / 6.33M withheld; Sherman 20.66M for / 4.82M withheld; Singhal 24.58M for / 0.91M withheld.
Ratified Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2025 (33.50M for, 31K against, 84K abstain).

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.